Serum erythropoietin levels in essential thrombocythemia: phenotypic and prognostic correlates
Serum erythropoietin levels in essential thrombocythemia: phenotypic and prognostic correlates, Published online: 19 November 2018; doi:10.1038/s41408-018-0157-5Serum erythropoietin levels in essential thrombocythemia: phenotypic and prognostic correlates (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 19, 2018 Category: Hematology Authors: Natasha Szuber Sravanthi Lavu Mythri Mudireddy Maura Nicolosi Domenico Penna Rangit R. Vallapureddy Terra L. Lasho Christy Finke Curtis A. Hanson Rhett P. Ketterling Animesh Pardanani Naseema Gangat Ayalew Tefferi Source Type: research

Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: Mayo Clinic case series of 309 patients
Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: Mayo Clinic case series of 309 patients, Published online: 19 November 2018; doi:10.1038/s41408-018-0156-6Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: Mayo Clinic case series of 309 patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 19, 2018 Category: Hematology Authors: N. Fan S. Lavu C. A. Hanson A. Tefferi Source Type: research

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)
Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC), Published online: 19 November 2018; doi:10.1038/s41408-018-0153-9Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC) (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 19, 2018 Category: Hematology Authors: L. Sanoja-Flores J. Flores-Montero J. J. Garc és B. Paiva N. Puig A. Garc ía-Mateo O. Garc ía-Sánchez A. Corral-Mateos L. Burgos E. Blanco J. Hern ández-Martín R. Pontes M. D íez-Campelo P. Millacoy P. Rodr íguez-Otero F. Prosper J. Merino M. B. V Source Type: research

Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP)
Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP), Published online: 15 November 2018; doi:10.1038/s41408-018-0150-zCorrespondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP) (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 15, 2018 Category: Hematology Authors: Rosanna Parasole Maria G. Valsecchi Daniela Silvestri Franco Locatelli Elena Barisone Fara Petruzziello M. Caterina Putti Concetta Micalizzi Antonella Colombini Rossella Mura Tommaso Mina Anna M. Testi Lucia D. Notarangelo Nicola Santoro Tommaso Casini Ca Source Type: research

Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma
Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma, Published online: 15 November 2018; doi:10.1038/s41408-018-0140-1Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 15, 2018 Category: Hematology Authors: Praful Ravi Shaji K. Kumar Lindsey Roeker Wilson Gonsalves Francis Buadi Martha Q. Lacy Ronald S. Go Angela Dispenzieri Prashant Kapoor John A. Lust David Dingli Yi Lin Stephen J. Russell Nelson Leung Morie A. Gertz Robert A. Kyle P. Leif Bergsagel S. Vin Source Type: research

Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosis
Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosis, Published online: 14 November 2018; doi:10.1038/s41408-018-0146-8Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 14, 2018 Category: Hematology Authors: Sihem Tarfi V éronique Harrivel Florent Dumezy Julien Guy Mikael Roussel Aguirre Mimoun Pierre Fenaux Nicolas Chapuis Eric Solary Doroth ée Selimoglu-Buet Orianne Wagner-Ballon Source Type: research

Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases
Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases, Published online: 12 November 2018; doi:10.1038/s41408-018-0151-yHydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 12, 2018 Category: Hematology Authors: Valerio De Stefano Elena Rossi Alessandra Carobbio Arianna Ghirardi Silvia Betti Guido Finazzi Alessandro M. Vannucchi Tiziano Barbui Source Type: research

Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma
Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma, Published online: 12 November 2018; doi:10.1038/s41408-018-0138-8Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 12, 2018 Category: Hematology Authors: Jing Jing Han Megan O ’byrne Mary J. Stenson Matthew J. Maurer Linda E. Wellik Andrew L. Feldman Ellen D. McPhail Thomas E. Witzig Mamta Gupta Source Type: research

Whole exome sequencing identifies recessive germline mutations in FAM160A1 in familial NK/T cell lymphoma
Whole exome sequencing identifies recessive germline mutations in FAM160A1 in familial NK/T cell lymphoma, Published online: 12 November 2018; doi:10.1038/s41408-018-0149-5Whole exome sequencing identifies recessive germline mutations in FAM160A1 in familial NK/T cell lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 12, 2018 Category: Hematology Authors: Jason Yongsheng Chan Alvin Yu Jin Ng Chee Leong Cheng Maarja-Liisa Nairism ägi Byrappa Venkatesh Daryl Ming Zhe Cheah Shao-Tzu Li Sock Hoai Chan Joanne Ngeow Yurike Laurensia Jing Quan Lim Jane Wan Lu Pang Sanjanaa Nagarajan Tammy Song Burton Chia Jing T Source Type: research

Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use
Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use, Published online: 12 November 2018; doi:10.1038/s41408-018-0148-6Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 12, 2018 Category: Hematology Authors: Ulrike Bacher Evgenii Shumilov Johanna Flach Naomi Porret Raphael Joncourt Gertrud Wiedemann Martin Fiedler Urban Novak Ursula Amstutz Thomas Pabst Source Type: research

Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting
Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting, Published online: 09 November 2018; doi:10.1038/s41408-018-0141-0Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 9, 2018 Category: Hematology Authors: Paul G. Richardson Jesus F. San Miguel Philippe Moreau Roman Hajek Meletios A. Dimopoulos Jacob P. Laubach Antonio Palumbo Katarina Luptakova Dorothy Romanus Tomas Skacel Shaji K. Kumar Kenneth C. Anderson Source Type: research

Evolving changes in M-protein and hemoglobin as predictors for progression of smoldering multiple myeloma
Evolving changes in M-protein and hemoglobin as predictors for progression of smoldering multiple myeloma, Published online: 08 November 2018; doi:10.1038/s41408-018-0144-xEvolving changes in M-protein and hemoglobin as predictors for progression of smoldering multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 8, 2018 Category: Hematology Authors: Shebli Atrash Myra Robinson Daniel Slaughter Amanda Aneralla Taylor Brown Jordan Robinson Ami Ndiaye Chelsea Sprouse Qing Zhang James T. Symanowski Reed Friend Peter M. Voorhees Saad Z. Usmani Manisha Bhutani Source Type: research

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials, Published online: 08 November 2018; doi:10.1038/s41408-018-0145-9Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 8, 2018 Category: Hematology Authors: A. Castellino A. Chiappella B. R. LaPlant L. D. Pederson G. Gaidano W. R. Macon G. Inghirami C. B. Reeder A. Tucci R. L. King A. Congiu J. M. Foran V. Pavone C. E. Rivera M. Spina S. M. Ansell F. Cavallo A. L. Molinari Giovannino Ciccone T. M. Habermann T Source Type: research

Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma, Published online: 08 November 2018; doi:10.1038/s41408-018-0147-7Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 8, 2018 Category: Hematology Authors: M. Hasib Sidiqi Mohammed A. Aljama Irbaz Bin Riaz Angela Dispenzieri Eli Muchtar Francis K. Buadi Rahma Warsame Martha Q. Lacy David Dingli Nelson Leung Wilson I. Gonsalves Prashant Kapoor Taxiarchis V. Kourelis William J. Hogan S. Vincent Rajkumar Shaji Source Type: research

Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts
Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts, Published online: 08 November 2018; doi:10.1038/s41408-018-0139-7Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 8, 2018 Category: Hematology Authors: Sylvia Faict Jos éphine Muller Kim De Veirman Elke De Bruyne Ken Maes Louise Vrancken Roy Heusschen Hendrik De Raeve Rik Schots Karin Vanderkerken Jo Caers Eline Menu Source Type: research

Targeting myeloid cells to prevent recurrent stroke in general population: the lesson of hydroxyurea in myeloproliferative neoplasms
Targeting myeloid cells to prevent recurrent stroke in general population: the lesson of hydroxyurea in myeloproliferative neoplasms, Published online: 07 November 2018; doi:10.1038/s41408-018-0143-yTargeting myeloid cells to prevent recurrent stroke in general population: the lesson of hydroxyurea in myeloproliferative neoplasms (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 7, 2018 Category: Hematology Authors: Tiziano Barbui Guido Finazzi Alessandro M. Vannucchi Valerio De Stefano Source Type: research

Prefibrotic myelofibrosis: treatment algorithm 2018
Prefibrotic myelofibrosis: treatment algorithm 2018, Published online: 07 November 2018; doi:10.1038/s41408-018-0142-zPrefibrotic myelofibrosis: treatment algorithm 2018 (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 7, 2018 Category: Hematology Authors: Guido Finazzi Alessandro M. Vannucchi Tiziano Barbui Source Type: research

Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study
Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study, Published online: 07 November 2018; doi:10.1038/s41408-018-0135-yLonger procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prosp...
Source: Blood Cancer Journal - November 7, 2018 Category: Hematology Authors: Despina Fotiou Theodoros N. Sergentanis Loula Papageorgiou Kimon Stamatelopoulos Maria Gavriatopoulou Efstathios Kastritis Theodora Psaltopoulou Stella Salta Patrick Van Dreden Rabiatou Sangare Annette K. Larsen Evangelos Terpos Ismail Elalamy Meletios A. Source Type: research

Effect of the BTK inhibitor ibrutinib on macrophage- and γδ T cell-mediated response against Mycobacterium tuberculosis
Effect of the BTK inhibitor ibrutinib on macrophage- and γδ T cell-mediated response against Mycobacterium tuberculosisEffect of the BTK inhibitor ibrutinib on macrophage- and γδ T cell-mediated response against Mycobacterium tuberculosis, Published online: 05 November 2018; doi:10.1038/s41408-018-0136-xEffect of the BTK inhibitor ibrutinib on macrophage- and γδ T cell-mediated response against Mycobacterium tuberculosis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 5, 2018 Category: Hematology Authors: Ana Colado Melanie Genoula C éline Cougoule Jos é L. Marín Franco Mar ía B. Almejún Denise Risnik Denise Kviatcovsky Enrique Podaza Esteban E. El ías Federico Fuentes Isabelle Maridonneau-Parini Fernando R. Bezares Horacio Fernandez Grecco Mar ía C Source Type: research

Deferred autologous stem cell transplantation in systemic AL amyloidosis
Deferred autologous stem cell transplantation in systemic AL amyloidosis, Published online: 05 November 2018; doi:10.1038/s41408-018-0137-9Deferred autologous stem cell transplantation in systemic AL amyloidosis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 5, 2018 Category: Hematology Authors: Richa Manwani Ute Hegenbart Shameem Mahmood Sajitha Sachchithanantham Charalampia Kyriakou Kwee Yong Rakesh Popat Neil Rabin Carol Whelan Tobias Dittrich Christoph Kimmich Philip Hawkins Stefan Sch önland Ashutosh Wechalekar Source Type: research

CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma
CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma, Published online: 22 October 2018; doi:10.1038/s41408-018-0127-yCD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 22, 2018 Category: Hematology Authors: Hiroko Nishida Mutsumi Hayashi Chikao Morimoto Michiie Sakamoto Taketo Yamada Source Type: research

Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens
Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens, Published online: 19 October 2018; doi:10.1038/s41408-018-0134-zLow-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 19, 2018 Category: Hematology Authors: George Z. Rassidakis Nikolas Herold Ida Hed Myrberg Nikolaos Tsesmetzis Sean G. Rudd Jan-Inge Henter Torsten Schaller Siok-Bian Ng Wee Joo Chng Benedict Yan Chin Hin Ng Farhad Ravandi Michael Andreeff Hagop M. Kantarjian L. Jeffrey Medeiros Ioanna Xagorar Source Type: research

Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry
Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry, Published online: 10 October 2018; doi:10.1038/s41408-018-0132-1Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 10, 2018 Category: Hematology Authors: Linda B. Baughn Kathryn Pearce Dirk Larson Mei-Yin Polley Eran Elhaik Michael Baird Colin Colby Joanne Benson Zhuo Li Yan Asmann Terry Therneau James R. Cerhan Celine M. Vachon A. Keith Stewart P. Leif Bergsagel Angela Dispenzieri Shaji Kumar S. Vincent R Source Type: research

Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma
Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma, Published online: 09 October 2018; doi:10.1038/s41408-018-0130-3Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 9, 2018 Category: Hematology Authors: Kerstin Wenzl Michelle K. Manske Vivekananda Sarangi Yan W. Asmann Patricia T. Greipp Hanna R. Schoon Esteban Braggio Matthew J. Maurer Andrew L. Feldman Thomas E. Witzig Susan L. Slager Stephen M. Ansell James R. Cerhan Anne J. Novak Source Type: research

Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group
Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group, Published online: 04 October 2018; doi:10.1038/s41408-018-0124-1Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 4, 2018 Category: Hematology Authors: Lia A. Moulopoulos Vassilis Koutoulidis Jens Hillengass Elena Zamagni Jesus D. Aquerreta Charles L. Roche Suzanne Lentzsch Philippe Moreau Michele Cavo Jesus San Miguel Meletios A. Dimopoulos S. Vincent Rajkumar Brian G. M. Durie Evangelos Terpos Stefan D Source Type: research

Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo
Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo, Published online: 04 October 2018; doi:10.1038/s41408-018-0133-0Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 4, 2018 Category: Hematology Authors: Emmanuelle Verger Juliette Soret-Dulphy Nabih Maslah Lydia Roy Jerome Rey Zineb Ghrieb Robert Kralovics Heinz Gisslinger Barbara Grohmann-Izay Christoph Klade Christine Chomienne St éphane Giraudier Bruno Cassinat Jean-Jacques Kiladjian Source Type: research

Chronic lymphocytic leukemia treatment algorithm 2018
Chronic lymphocytic leukemia treatment algorithm 2018, Published online: 03 October 2018; doi:10.1038/s41408-018-0131-2Chronic lymphocytic leukemia treatment algorithm 2018 (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 3, 2018 Category: Hematology Authors: Sameer A. Parikh Source Type: research

Role of apurinic/apyrimidinic nucleases in the regulation of homologous recombination in myeloma: mechanisms and translational significance
Role of apurinic/apyrimidinic nucleases in the regulation of homologous recombination in myeloma: mechanisms and translational significance, Published online: 25 September 2018; doi:10.1038/s41408-018-0129-9Role of apurinic/apyrimidinic nucleases in the regulation of homologous recombination in myeloma: mechanisms and translational significance (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 25, 2018 Category: Hematology Authors: Subodh Kumar Srikanth Talluri Jagannath Pal Xiaoli Yuan Renquan Lu Puru Nanjappa Mehmet K. Samur Nikhil C. Munshi Masood A. Shammas Source Type: research

Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project, Published online: 21 September 2018; doi:10.1038/s41408-018-0128-xGender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 21, 2018 Category: Hematology Authors: Daniela Barraco Barbara Mora Paola Guglielmelli Elisa Rumi Margherita Maffioli Alessandro Rambaldi Marianna Caramella Rami Komrokji Jason Gotlib Jean Jacques Kiladjian Francisco Cervantes Timothy Devos Francesca Palandri Valerio De Stefano Marco Ruggeri R Source Type: research

The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q)
The impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q), Published online: 21 September 2018; doi:10.1038/s41408-018-0126-zThe impact of lenalidomide exposure on response and outcomes in patients with lower-risk myelodysplastic syndromes and del(5q) (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 21, 2018 Category: Hematology Authors: Mikkael A. Sekeres Arlene S. Swern Aristoteles Giagounidis Alan F. List Dominik Selleslag Moshe Mittelman Brigitte Schlegelberger Gudrun G öhring Jack Shiansong Li Mary M. Sugrue Pierre Fenaux Source Type: research

Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib
Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib, Published online: 03 September 2018; doi:10.1038/s41408-018-0122-3Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 3, 2018 Category: Hematology Authors: Oliver Ottmann Giuseppe Saglio Jane F. Apperley Christopher Arthur Eduardo Bullorsky Aude Charbonnier John F. Dipersio Hagop Kantarjian Hanna Jean Khoury Dong-Wook Kim Diane Healey Lewis Strauss Jorge E. Cortes Source Type: research

GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia, Published online: 31 August 2018; doi:10.1038/s41408-018-0123-2GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 31, 2018 Category: Hematology Authors: Feng-Ming Tien Hsin-An Hou Cheng-Hong Tsai Jih-Luh Tang Yu-Chiao Chiu Chien-Yuan Chen Yuan-Yeh Kuo Mei-Hsuan Tseng Yen-Ling Peng Ming-Chih Liu Chia-Wen Liu Xiu-Wen Liao Liang-In Lin Chien-Ting Lin Shang-Ju Wu Bor-Sheng Ko Szu-Chun Hsu Shang-Yi Huang Ming Source Type: research

Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG study
Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG study, Published online: 29 August 2018; doi:10.1038/s41408-018-0110-7Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 29, 2018 Category: Hematology Authors: Joseph Mikhael Judith Manola Amylou C. Dueck Suzanne Hayman Kurt Oettel Abraham S. Kanate Sagar Lonial S. Vincent Rajkumar Source Type: research

Biological determinants of health disparities in multiple myeloma
Biological determinants of health disparities in multiple myeloma, Published online: 28 August 2018; doi:10.1038/s41408-018-0118-zBiological determinants of health disparities in multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 28, 2018 Category: Hematology Authors: Cheryl Jacobs Smith Stefan Ambs Ola Landgren Source Type: research

Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome
Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome, Published online: 22 August 2018; doi:10.1038/s41408-018-0112-5Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 22, 2018 Category: Hematology Authors: Julia J. Unterluggauer Katharina Prochazka Peter V. Tomazic Heinrich J. Huber Rita Seeboeck Karoline Fechter Elisabeth Steinbauer Verena Gruber Julia Feichtinger Martin Pichler Marc A. Weniger Ralf K üppers Heinz Sill Rudolf Schicho Peter Neumeister Chri Source Type: research

Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia, Published online: 22 August 2018; doi:10.1038/s41408-018-0117-0Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 22, 2018 Category: Hematology Authors: Lia Gore Franco Locatelli Gerhard Zugmaier Rupert Handgretinger Maureen M. O ’Brien Peter Bader Deepa Bhojwani Paul-Gerhardt Schlegel Catherine A. Tuglus Arend von Stackelberg Source Type: research

Dissecting causes for improved survival among patients with acute myeloid leukemia in two different eras receiving identical regimens in sequential randomized studies
Dissecting causes for improved survival among patients with acute myeloid leukemia in two different eras receiving identical regimens in sequential randomized studies, Published online: 22 August 2018; doi:10.1038/s41408-018-0121-4Dissecting causes for improved survival among patients with acute myeloid leukemia in two different eras receiving identical regimens in sequential randomized studies (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 22, 2018 Category: Hematology Authors: Ing S. Tiong John Reynolds Kenneth F. Bradstock John F. Seymour Andrew H. Wei Source Type: research

The biological significance of histone modifiers in multiple myeloma: clinical applications
The biological significance of histone modifiers in multiple myeloma: clinical applications, Published online: 22 August 2018; doi:10.1038/s41408-018-0119-yThe biological significance of histone modifiers in multiple myeloma: clinical applications (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 22, 2018 Category: Hematology Authors: Hiroto Ohguchi Teru Hideshima Kenneth C. Anderson Source Type: research

The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome, Published online: 13 August 2018; doi:10.1038/s41408-018-0115-2The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 13, 2018 Category: Hematology Authors: Yi-Tsung Yang Yu-Chiao Chiu Chein-Jun Kao Hsin-An Hou Chien-Chin Lin Cheng-Hong Tsai Mei-Hsuan Tseng Wen-Chien Chou Hwei-Fang Tien Source Type: research

RBFOX2 and alternative splicing in B-cell lymphoma
RBFOX2 and alternative splicing in B-cell lymphoma, Published online: 10 August 2018; doi:10.1038/s41408-018-0114-3RBFOX2 and alternative splicing in B-cell lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 10, 2018 Category: Hematology Authors: Hilmar Quentmeier Claudia Pommerenke Stephan H. Bernhart Wilhelm G. Dirks Vivien Hauer Steve Hoffmann Stefan Nagel Reiner Siebert Cord C. Uphoff Margarete Zaborski Hans G. Drexler Source Type: research

Heterogeneous prognosis among KIT mutation types in adult acute myeloid leukemia patients with t(8;21)
Heterogeneous prognosis among KIT mutation types in adult acute myeloid leukemia patients with t(8;21), Published online: 07 August 2018; doi:10.1038/s41408-018-0116-1Heterogeneous prognosis among KIT mutation types in adult acute myeloid leukemia patients with t(8;21) (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 7, 2018 Category: Hematology Authors: Ya-Zhen Qin Hong-Hu Zhu Qian Jiang Lan-Ping Xu Hao Jiang Yu Wang Xiao-Su Zhao Yan-Rong Liu Xiao-Hui Zhang Kai-Yan Liu Xiao-Jun Huang Source Type: research

Multiple myeloma: family history and mortality in second primary cancers
Multiple myeloma: family history and mortality in second primary cancers, Published online: 07 August 2018; doi:10.1038/s41408-018-0108-1Multiple myeloma: family history and mortality in second primary cancers (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 7, 2018 Category: Hematology Authors: Subhayan Chattopadhyay Hongyao Yu Amit Sud Jan Sundquist Asta F örsti Akseli Hemminki Kari Hemminki Source Type: research

History of autoimmune conditions and lymphoma prognosis
History of autoimmune conditions and lymphoma prognosis, Published online: 01 August 2018; doi:10.1038/s41408-018-0105-4History of autoimmune conditions and lymphoma prognosis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 1, 2018 Category: Hematology Authors: Geffen Kleinstern Matthew J. Maurer Mark Liebow Thomas M. Habermann Jean L. Koff Cristine Allmer Thomas E. Witzig Grzegorz S. Nowakowski Ivana N. Micallef Patrick B. Johnston David J. Inwards Carrie A. Thompson Andrew L. Feldman Brian K. Link Christopher Source Type: research

Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort
Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort, Published online: 01 August 2018; doi:10.1038/s41408-018-0111-6Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 1, 2018 Category: Hematology Authors: Elodie Bohers Pierre-Julien Viailly St éphanie Becker Vinciane Marchand Philippe Ruminy Catherine Maingonnat Philippe Bertrand Pascaline Etancelin Jean-Michel Picquenot Vincent Camus Anne-Lise Menard Emilie Lemasle Nathalie Contentin St éphane Leprêtre Source Type: research

Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma, Published online: 31 July 2018; doi:10.1038/s41408-018-0104-5Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - July 31, 2018 Category: Hematology Authors: Dharshan Sivaraj Michael M Green Yubin Kang Gwynn D Long David A Rizzieri Zhiguo Li Anderson H Garrett Jackie L McIntyre Nelson J Chao Cristina Gasparetto Source Type: research

Myelofibrosis Treatment Algorithm 2018
Myelofibrosis Treatment Algorithm 2018, Published online: 31 July 2018; doi:10.1038/s41408-018-0109-0Myelofibrosis Treatment Algorithm 2018 (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - July 31, 2018 Category: Hematology Authors: Ayalew Tefferi Paola Guglielmelli Animesh Pardanani Alessandro M. Vannucchi Source Type: research

Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma
Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma, Published online: 30 July 2018; doi:10.1038/s41408-018-0106-3Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - July 30, 2018 Category: Hematology Authors: Shaji K. Kumar Francis K. Buadi Betsy LaPlant Alese Halvorson Nelson Leung Prashant Kapoor David Dingli Morie A. Gertz Ronald S. Go P. Leif Bergsagel Yi Lin Angela Dispenzieri Yi Lisa Hwa Amie Fonder Miriam Hobbs Rafael Fonseca Suzanne R. Hayman A. Keith Source Type: research

Clonal hematopoiesis in patients with rheumatoid arthritis
Clonal hematopoiesis in patients with rheumatoid arthritis, Published online: 26 July 2018; doi:10.1038/s41408-018-0107-2Clonal hematopoiesis in patients with rheumatoid arthritis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - July 26, 2018 Category: Hematology Authors: Paula Savola Sofie Lundgren Mikko A. I. Ker änen Henrikki Almusa Pekka Ellonen Marjatta Leirisalo-Repo Tiina Kelkka Satu Mustjoki Source Type: research

High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia
High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia, Published online: 19 July 2018; doi:10.1038/s41408-018-0103-6High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - July 19, 2018 Category: Hematology Authors: Miriam Marquis Cyrielle Beaubois Vincent-Philippe Lavall ée Michal Abrahamowicz Coraline Danieli S ébastien Lemieux Imran Ahmad Andrew Wei Stephen B. Ting Shaun Fleming Anthony Schwarer David Grimwade William Grey Robert K. Hills Paresh Vyas Nigel Russe Source Type: research

Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials
Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials, Published online: 06 July 2018; doi:10.1038/s41408-018-0102-7Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - July 6, 2018 Category: Hematology Authors: Sikander Ailawadhi Susanna Jacobus Rachael Sexton Alexander K. Stewart Angela Dispenzieri Mohamad A. Hussein Jeffrey A. Zonder John Crowley Antje Hoering Bart Barlogie Robert Z. Orlowski S. Vincent Rajkumar Source Type: research